Cargando…

The Immunomodulatory Effect of the Gut Microbiota in Kidney Disease

The human gut microbiota is a complex cluster composed of 100 trillion microorganisms, which holds a symbiotic relationship with the host under normal circumstances. Intestinal flora can facilitate the treatment of human metabolic dysfunctions and interact with the intestinal tract, which could infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Mingxuan, Ma, Kuai, Wang, Jing, Ding, Zhaolun, Li, Yunlong, Zhu, Shaomi, Liang, Xin, Zhang, Qinxiu, Song, Linjiang, Liu, Chi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140847/ https://www.ncbi.nlm.nih.gov/pubmed/34095319 http://dx.doi.org/10.1155/2021/5516035

Ejemplares similares

Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease
por: Li, Yunlong, et al.
Publicado: (2021)

Immunological Involvement of MicroRNAs in the Key Events of Systemic Lupus Erythematosus
por: Chi, Mingxuan, et al.
Publicado: (2021)

Kidney diseases and long non-coding RNAs in the limelight
por: Liu, Chenxin, et al.
Publicado: (2022)

Revisiting Lung Cancer Metastasis: Insight From the Functions of Long Non-coding RNAs
por: Huang, Peng, et al.
Publicado: (2021)

Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo
por: Zeng, Anqi, et al.
Publicado: (2020)

The Therapeutic Effect of Stem Cells on Chemotherapy-Induced Premature Ovarian Failure
por: Chen, Haoran, et al.
Publicado: (2021)

Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives
por: Huang, Peng, et al.
Publicado: (2021)

Granulocyte Colony-Stimulating Factor Combined With Transcutaneous Electrical Acupoint Stimulation in Treatment of Unresponsive Thin Endometrium in Frozen Embryo Transfer Cycles
por: Song, Linjiang, et al.
Publicado: (2021)

Chlorogenic acid induces apoptosis, inhibits metastasis and improves antitumor immunity in breast cancer via the NF-κB signaling pathway
por: Zeng, Anqi, et al.
Publicado: (2021)

Role of lncRNAs in the pathogenic mechanism of human decreased ovarian reserve
por: Lv, Zhexi, et al.
Publicado: (2023)

Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer
por: Song, Linjiang, et al.
Publicado: (2020)

Therapeutic approaches to colorectal cancer via strategies based on modulation of gut microbiota
por: Chen, Maohua, et al.
Publicado: (2022)

Estradiol pretreatment in GnRH antagonist protocol for IVF/ICSI treatment
por: Zhu, Shaomi, et al.
Publicado: (2022)

The Crosstalk Between Long Non-Coding RNAs and Various Types of Death in Cancer Cells
por: Tang, Wenwen, et al.
Publicado: (2021)

The diseased kidney: aging and senescent immunology
por: Chi, Mingxuan, et al.
Publicado: (2022)

Role of Gut Microbiota and Oxidative Stress in the Progression of Transplant-Related Complications following Hematopoietic Stem Cell Transplantation
por: Chi, Mingxuan, et al.
Publicado: (2023)

A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives
por: Han, Zhongyu, et al.
Publicado: (2022)

Heterotopic Pregnancy Secondary to in vitro Fertilization-Embryo Transfer: Risk Factors and Pregnancy Outcomes
por: Zhu, Shaomi, et al.
Publicado: (2022)

Regulatory function of DNA methylation mediated lncRNAs in gastric cancer
por: Li, Nan, et al.
Publicado: (2022)

Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis
por: Xu, Huihui, et al.
Publicado: (2020)

The Immunomodulatory Effect of β-Glucan Depends on the Composition of the Gut Microbiota
por: Sung, Miseon, et al.
Publicado: (2023)

Targeting Immunomodulatory Agents to the Gut-Associated Lymphoid Tissue
por: Zgair, Atheer, et al.
Publicado: (2016)

Gut microbiota–derived short-chain fatty acids and kidney diseases
por: Li, Lingzhi, et al.
Publicado: (2017)

The potential immunomodulatory role of the gut microbiota in the pathogenesis of asthma: an in vitro study
por: Kleniewska, Paulina, et al.
Publicado: (2023)

Chronic kidney disease and gut microbiota
por: Amini Khiabani, Siamak, et al.
Publicado: (2023)

The clinical impact of gut microbiota in chronic kidney disease
por: Kim, So Mi, et al.
Publicado: (2020)

Characteristics of Serum Metabolites and Gut Microbiota in Diabetic Kidney Disease
por: Zhang, Bo, et al.
Publicado: (2022)

Gut microbiota and diabetic kidney diseases: Pathogenesis and therapeutic perspectives
por: Lin, Jia-Ran, et al.
Publicado: (2022)

The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
por: Wang, Yuwei, et al.
Publicado: (2022)

Intestinal Immunomodulatory Cells (T Lymphocytes): A Bridge between Gut Microbiota and Diabetes
por: Li, Qingwei, et al.
Publicado: (2018)

Effects of Lactiplantibacillus plantarum 19-2 on immunomodulatory function and gut microbiota in mice
por: Wang, Xiaoran, et al.
Publicado: (2022)

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
por: Huang, Yinghui, et al.
Publicado: (2022)

Homeostasis in the Gut Microbiota in Chronic Kidney Disease
por: Bhargava, Shruti, et al.
Publicado: (2022)

Role of the Gut Microbiota in Children with Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2023)

Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
por: Yu, Shunying, et al.
Publicado: (2022)

Antitumor Activity of Carboxymethyl Pachymaran with Different Molecular Weights Based on Immunomodulatory and Gut Microbiota
por: Zhao, Yalin, et al.
Publicado: (2023)

Alteration of the gut microbiota in Chinese population with chronic kidney disease
por: Jiang, Shuanghong, et al.
Publicado: (2017)

Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease
por: Wu, I-Wen, et al.
Publicado: (2020)

Autophagy-related lncRNAs in tumor progression and drug resistance: A double-edged sword
por: Zhang, Yunchao, et al.
Publicado: (2023)

Gut microbiota and inflammation in chronic kidney disease patients
por: Mafra, Denise, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9bgagkac22o6cu9piu48t0dlgj